Zacks Research Has Bullish Forecast for CPRX Q2 Earnings
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Analysts at Zacks Research raised their Q2 2025 earnings per share (EPS) estimates for shares of Catalyst Pharmaceuticals in a report released on Wednesday, May 28th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings per share of $0.52 for the quarter, […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Analysts at Zacks Research raised their Q2 2025 earnings per share (EPS) estimates for shares of Catalyst Pharmaceuticals in a report released on Wednesday, May 28th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings per share of $0.52 for the quarter, […]
